Historical record - last NADAC publication: 4/19/2023
Product Information
OXYMORPHONE HCL 5 MG TABLET is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.5201 per EA under NDC 00054028325. Its NADAC has been published 542 times since Nov 28, 2013.
Strength
5 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054028325
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
4/19/2023
Active Ingredients
OXYMORPHONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090964On Market Since
9/27/2010
Pharmacological Classes
Price Statistics
The NADAC for OXYMORPHONE HCL 5 MG TABLET has been published 542 times since Nov 28, 2013, and over the history we have for it it has declined 74.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5201 per EA |
|---|---|
| All-time high | $2.1959 (Jan 15, 2014) |
| All-time low | $0.3420 (Sep 23, 2020) |
| Median price | $0.9216 |
| Average price | $1.0244 |
| Largest weekly change | +123.9% (Dec 23, 2020) |
| Weeks tracked | 542 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the oxymorphone hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of OXYMORPHONE HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYMORPHONE HCL 5 MG TABLET, manufactured by Hikma Pharmaceuticals USA Inc., is $0.5201 per EA (NDC 00054028325), effective Apr 10, 2024.
How has the price of OXYMORPHONE HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYMORPHONE HCL 5 MG TABLET has declined 74.6%. It has been tracked across 542 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for OXYMORPHONE HCL 5 MG TABLET?
Since Nov 28, 2013, the NADAC for OXYMORPHONE HCL 5 MG TABLET has ranged from a low of $0.3420 (Sep 23, 2020) to a high of $2.1959 (Jan 15, 2014), with a median of $0.9216 per EA.
Are there cheaper alternatives to OXYMORPHONE HCL 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of OXYMORPHONE HCL 5 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures OXYMORPHONE HCL 5 MG TABLET?
OXYMORPHONE HCL 5 MG TABLET (NDC 00054028325) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification